Excessive time spent on social media increases children’s and teens’ risk of developing an eating disorder, a new study warns. Each additional hour of total screen time or social media use raises the likelihood that a kid...

Florida’s six-week abortion ban caused the state’s abortion rate to drop dramatically, new research shows. Abortions in Florida dropped to an estimated 5,630 in May and 5,200 in June, a 30% and 35% decrease from the average...

Humans could learn a few medical tips from their gorilla cousins, a new study says. Four plants used by wild gorillas in Gabon have antibacterial and antioxidant properties, researcher reported Sept. 11 in the journal PLOS One....

Fear of a having a low blood sugar crash dissuades many people with type 1 diabetes from getting the exercise they need, a new study finds. However, people were more likely to engage in exercise if their...

Statistics from 2023 on U.S. obesity rates bring no good news: In every state in the nation, 1 in every 5 people is now obese, the new tally shows. In 2013, not one state had an adult...

It could be a real breakthrough for people at risk for HIV infection: A shot given every six months that reduces their risk by a whopping 96%. That’s according to new trial results released Thursday by Gilead...

An ingredient in the hair dye a French woman used caused her to develop a vision-robbing retinopathy, researchers report. When she switched to a dye without these ingredients, called aromatic amines, her vision troubles resolved, according to...

Prescriptions for amphetamine stimulants to treat ADHD have increased significantly in recent years, particularly during the pandemic. Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a...

The number of Americans with a potentially dangerous heart rhythm condition is three times greater than previously thought, a new study claims. An estimated 5% of the population — 10.5 million U.S. adults — have atrial fibrillation,...

The injectable weight-loss drug Zepbound appears to work better in women than in men, according to a new analysis of the clinical trials that led to its approval. All doses of tirzepatide consistently reduced weight in both...